Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study
Mark Matza, Cory A. Perugino, Liam Harvey, Ana D. Fernandes, Zachary S. Wallace, Hang Liu, Hugues Allard‐Chamard, Shiv Pillai, John H. Stone
Topics & Concepts
MedicineAbataceptPrednisoneInternal medicineClinical endpointOpen labelRheumatologyProspective cohort studyPhysical therapyClinical trialRituximabLymphomaIgG4-Related and Inflammatory DiseasesImmunodeficiency and Autoimmune DisordersGastrointestinal disorders and treatments